Specialty Pharmacy Clinical Policy Bulletins: Aetna Non-Medicare Prescription Drug Plan
Berberine does not touch GLP-1 receptors at all
Whilst there is no official contraindication preventing their concurrent use, the evidence supporting additional benefits from this combination remains limited
The 15LO1/PEBP1 pathway should be investigated as a novel asthma therapeutic target
It may help the body lose fat by reducing appetite, improving fullness, supporting blood sugar control, and making it easier to maintain a calorie deficit
Sources FDA Wegovy (semaglutide) prescribing information, 2025 FDA Ozempic (semaglutide) prescribing information, 2025 Mayo Clinic Semaglutide (subcutaneous route) side effects Journal of the American Academy of Dermatology Dermatologic findings associated with semaglutide use: a scoping review Pharmacy Times Injection-site reactions and how to manage them Novo Nordisk How to use your Wegovy pen Novo Nordisk How to use your Ozempic pen Medical disclaimer: This article is for informational purposes only